Glenmark Settles Lunesta Patent Spat With Sepracor
Glenmark Pharmaceuticals Ltd. has reached a settlement with Sepracor Inc., putting to rest a patent infringement fight launched by Sepracor over the insomnia treatment sold under the brand name Lunesta....To view the full article, register now.
Already a subscriber? Click here to view full article